Cargando…
Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer
BACKGROUND: Progression of colorectal cancer (CRC) has been explained by genomic abnormalities along with the adenoma-carcinoma sequence theory (ACS). The aim of our study is to elucidate whether the promoter DNA methylation of the cancer-specific methylation gene, cysteine dioxygenase 1 (CDO1), con...
Autores principales: | Kojima, Keita, Nakamura, Takatoshi, Ohbu, Makoto, Katoh, Hiroshi, Ooizumi, Yosuke, Igarashi, Kazuharu, Ishii, Satoru, Tanaka, Toshimichi, Yokoi, Keigo, Nishizawa, Nobuyuki, Yokota, Kazuko, Kosaka, Yoshimasa, Sato, Takeo, Watanabe, Masahiko, Yamashita, Keishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944981/ https://www.ncbi.nlm.nih.gov/pubmed/29746493 http://dx.doi.org/10.1371/journal.pone.0194785 |
Ejemplares similares
-
Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer
por: Kojima, Keita, et al.
Publicado: (2019) -
Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease
por: Igarashi, Kazuharu, et al.
Publicado: (2017) -
Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer
por: Nishizawa, Nobuyuki, et al.
Publicado: (2019) -
Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin
por: Kojima, Keita, et al.
Publicado: (2019) -
Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer
por: Harada, Hiroki, et al.
Publicado: (2019)